Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aminohippuric acid
Drug ID BADD_D00109
Description The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]
Indications and Usage Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.
Marketing Status Discontinued
ATC Code V04CH30
DrugBank ID DB00345
KEGG ID D06890
MeSH ID D010130
PubChem ID 2148
TTD Drug ID D04DLM
NDC Product Code Not Available
Synonyms p-Aminohippuric Acid | p Aminohippuric Acid | para-Aminohippuric Acid | para Aminohippuric Acid | 4-Aminohippuric Acid | 4 Aminohippuric Acid | Aminohippuric Acid | Nephrotest | p-Aminohippurate | p Aminohippurate | Aminohippurate Sodium | Sodium, Aminohippurate | Sodium Para-Aminohippurate | Para-Aminohippurate, Sodium | Sodium Para Aminohippurate
Chemical Information
Molecular Formula C9H10N2O3
CAS Registry Number 61-78-9
SMILES C1=CC(=CC=C1C(=O)NCC(=O)O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Feeling hot08.01.09.009--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Hypersensitivity10.01.03.003--
Muscle spasms15.05.03.004--
Nausea07.01.07.001--
Paraesthesia17.02.06.005--
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
The 1th Page    1    Total 1 Pages